Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies

Dermatology

Volumn 211, Issue 4, 2005, Pages 307-308

  Zachariae, H ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Alcohol; Arsenic; Cirrhosis; Liver biopsies; Liver fibrosis; Methotrexate; Psoriasis

Indexed keywords

ALCOHOL; ARSENIC; COLLAGEN TYPE 3; METHOTREXATE; RETINOL;

ALCOHOL CONSUMPTION; DISEASE COURSE; EDITORIAL; HUMAN; INCIDENCE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TOXICITY; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS;

ALCOHOL DRINKING; ARSENICALS; BIOLOGICAL MARKERS; BIOPSY; DERMATOLOGIC AGENTS; HUMANS; LIVER; LIVER CIRRHOSIS; METHOTREXATE; PEPTIDE FRAGMENTS; PROCOLLAGEN; PSORIASIS; VITAMIN A;

EID: 27844432697     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088497     Document Type: Editorial

References (16)

1. Roenigk H, Auerbach R, Maibach H, Weinstein G, Lebwohl M: Methotrexate in psoriasis: Consensus conference. J Am Acad Dermatol 1998;38:478-485.
2. Roenigk H: Methotrexate; in Dubertret L (ed): Psoriasis. Brescia, ISED, 1994, pp 162-173.
3. Zachariae H: Liver biopsies and methotrexate: A time for reconsideration? J Am Acad Dermatol 2000;42:531-534.
4. Boffa M, Chalmers R, Haboubi N, Shomaf M, Mitchell D: Sequential liver biopsies during long-term methotrexate treatment for psoriasis: A reappraisal. Br J Dermatol 1995;133:774-778.
5. Aithal G, Haughk B, Das S, Card T, Burt A, Record C: Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: Are serial liver biopsies justified? Aliment Pharmacol Ther 2004;19:391-399.
6. Christensen E: Is liver biopsy necessary during low-dose methotrexate therapy? A hepatologist's view. Forum Nord Dermatol Venereol 2004;10:9-12.
7. Zachariae H, Kragballe K, Sogaard H: Methotrexate-induced liver cirrhosis: Studies including serial liver biopsies during continued treatment. Br J Dermatol 1980;192:407-412.
8. Nyfors A: Liver biopsies from psoriatics related to methotrexate therapy. Acta Pathol Microbiol Scand 1977;85:511-518.
9. Zachariae H, Sogaard H, Heickendorff L: Serum amino terminal propeptide of type III procollagen - A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics. Acta Derm Venereol 1988;69:241-243.
10. Zachariae H, Grunnet E, Sogaard H: Liver biopsy in methotrexate treated patients - A reevaluation. Acta Derm Venereol 1975;55:291-296.
11. Zachariae H: Arsenic and the risk for cancer. Ugeskr Laeg 1972;134:2720-2721.
12. Zachariae H, Sogaard H: Methotrexate-induced liver cirrhosis: A follow-up. Dermatologica 1987;75:178-182.
13. Grunnet E: Alcohol consumption in psoriasis. Dermatologica 1974;149:136-139.
14. Davidsson S, Blomqvist K, Molin L, Mork C, Sigurgeirsson B, Zachariae H, Zachariae R: Lifestyle of 6,497 Nordic psoriasis patients. J EADV 2001;15(suppl 2):243.
15. Zachariae H, Zachariae R, Blomqvist K, Molin L, Mork C, Davidsson S, Sigurgeirsson B: Treatment of psoriasis in the Nordic countries from 5,739 members of the psoriasis associations - Data from the Nordic quality of life study. Acta Derm Venereol 2001;81:116-121.
16. Zachariae H, Heickendorff L, Sogaard H: The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: A 10-year follow-up. Br J Dermatol 2001;143:100-103.